Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.39 |
| ▸ | MC4R | P32245 | 1/20 | 0.39 |
| ▸ | MC5R | P33032 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1611043 | 1.00 | SIGMAR1 (0.50) | SIGMAR1HDAC1HDAC8CYP1A2CYP2A6 | |
| SCHEMBL1610204 | 1.00 | SIGMAR1 (0.50) | SIGMAR1HDAC1HDAC8CYP1A2CYP2A6 | |
| SCHEMBL1611323 | 0.98 | SIGMAR1 (0.51) | SIGMAR1HDAC1HDAC8CYP1A2CYP2A6 | |
| SCHEMBL1610345 | 0.94 | SIGMAR1 (0.56) | SIGMAR1HDAC1HDAC8CYP1A2CYP2A6 | |
| SCHEMBL1610472 | 0.94 | SIGMAR1 (0.56) | SIGMAR1HDAC1HDAC8CYP1A2CYP2A6 | |
| SCHEMBL129049 | 0.94 | SIGMAR1 (0.56) | SIGMAR1HDAC1HDAC8CYP1A2CYP2A6 | |
| SCHEMBL27523237 | 0.93 | SIGMAR1 (0.54) | SIGMAR1HDAC1HDAC8CYP1A2CYP2A6 | |
| SCHEMBL1487677 | 0.92 | SIGMAR1 (0.53) | SIGMAR1HDAC1HDAC8CYP1A2CYP2A6 | |
| SCHEMBL133399 | 0.92 | SIGMAR1 (0.58) | SIGMAR1HDAC1HDAC8CYP1A2CYP2A6 | |
| SCHEMBL128560 | 0.86 | SIGMAR1 (0.59) | SIGMAR1HDAC1HDAC8CYP1A2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11718758-B2 | Aqueous dispersion of colored particles | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2023-08-08 | — | — | US | disclosed |
| EP-3725854-B1 | COLORED PARTICLE AQUEOUS DISPERSION | MITSUBISHI PENCIL CO (JP) | 2023-07-05 | — | — | EP | disclosed |
| CN-111465662-B | Aqueous dispersion of coloured particles | 三菱铅笔株式会社 | 2023-05-26 | — | — | CN | disclosed |
| US-20210071006-A1 | AQUEOUS DISPERSION OF COLORED PARTICLES | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2021-03-11 | — | — | US | disclosed |
| US-10913855-B2 | Silicon-containing heterocyclic compound, and quencher | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2021-02-09 | — | — | US | disclosed |
| EP-3725854-A1 | COLORED PARTICLE AQUEOUS DISPERSION | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2020-10-21 | — | — | EP | disclosed |
| US-10377713-B2 | Quencher | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-08-13 | — | — | US | disclosed |
| US-20190233651-A1 | SILICON-CONTAINING HETEROCYCLIC COMPOUND, AND QUENCHER | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-08-01 | — | — | US | disclosed |
| EP-3476901-A1 | SILICON-CONTAINING HETEROCYCLIC COMPOUND, AND QUENCHER | FUJIFILM Wako Pure Chemical Corporation (JP) | 2019-05-01 | — | — | EP | disclosed |
| EP-3444304-A1 | POLYFUNCTIONAL POLYMERIZABLE COMPOUND AND COLORED COMPOSITION | FUJIFILM Wako Pure Chemical Corporation (JP) | 2019-02-20 | — | — | EP | disclosed |
| US-20170342031-A1 | QUENCHER | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2017-11-30 | — | — | US | disclosed |
| EP-3235876-A1 | QUENCHER | Wako Pure Chemical Industries, Ltd. (JP) | 2017-10-25 | — | — | EP | disclosed |
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| EP-2248818-A1 | ORGANIC SEMICONDUCTOR MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10377713-B2 | Quencher | AHR, GFER, AKR1A1 | SIGMAR1 410/4885HDAC1 3014/4885HDAC8 4191/4885 |
| US-10913855-B2 | Silicon-containing heterocyclic compound, and quencher | ANXA11, ANXA1, ORAI2 | SIGMAR1 129/4885HDAC1 773/4885HDAC8 2460/4885 |
| US-20170342031-A1 | QUENCHER | AHR, GFER, AKR1A1 | SIGMAR1 410/4885HDAC1 3014/4885HDAC8 4191/4885 |
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | SIGMAR1 223/4885HDAC1 2752/4885HDAC8 4616/4885 |
| US-20190233651-A1 | SILICON-CONTAINING HETEROCYCLIC COMPOUND, AND QUENCHER | ANXA11, ANXA1, ORAI2 | SIGMAR1 124/4885HDAC1 739/4885HDAC8 2418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.